EPIC | SCLP |
Sector | Pharma and Biotech |
ISIN | GB00B63D3314 |
Market Sector | AIM |
Market Segment | ASQ1 |
Main Indices | FTSE AIM All-Share |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £84.45m |
NMS | 20,000 |
Shares in issue | 927.98m |
Date Listed | 30-Jul-2010 |
Currency | UK Pounds |
Share Price | 9.10p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 17.00 |
52 Week Low | 8.15 |
Volume | 0 |
Shares Issued | 927.98m |
Market Cap | £84.45m |
Beta | 0.07 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
CEO | Lindy Durrant |
CFO | Sath Nirmalananthan |
You are here: research